skip to main content

H.Res. 166: Expressing support for designation of March 3, 2019, as National Triple-Negative Breast Cancer Day.

The text of the bill below is as of Feb 28, 2019 (Introduced).


IV

116th CONGRESS

1st Session

H. RES. 166

IN THE HOUSE OF REPRESENTATIVES

February 28, 2019

submitted the following resolution; which was referred to the Committee on Oversight and Reform

RESOLUTION

Expressing support for designation of March 3, 2019, as National Triple-Negative Breast Cancer Day.

Whereas triple-negative breast cancer was recognized as a distinct type of cancer in 2006;

Whereas triple-negative breast cancer disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations;

Whereas triple-negative breast cancers are estrogen receptor-negative, progesterone receptor-negative, and HER2-negative, making them distinct from other breast cancers;

Whereas there is no targeted therapy for triple-negative breast cancers;

Whereas 10 to 20 percent of all breast cancer diagnoses are designated as triple-negative;

Whereas triple-negative breast cancer can be more aggressive and more likely to spread and recur;

Whereas triple-negative breast cancer accounts for around 25 percent of all deaths from breast cancer in the United States; and

Whereas March 3, 2019, would be an appropriate date to designate as National Triple-Negative Breast Cancer Day: Now, therefore, be it

That the House of Representatives supports the designation of National Triple-Negative Breast Cancer Day to create awareness of the devastating effect of these cancers on American families and the need for strong action to eradicate triple-negative breast cancer.